Search Results

There are 32974 results for: content related to: Consumer Information and Pharmaceutical Prices: Theory and Evidence *

  1. Competition between brand-name and generics – analysis on pricing of brand-name pharmaceutical

    Health Economics

    Volume 18, Issue 5, May 2009, Pages: 591–606, Ying Kong

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hec.1392

  2. Competition under consumer loss aversion

    The RAND Journal of Economics

    Volume 45, Issue 1, Spring 2014, Pages: 1–31, Heiko Karle and Martin Peitz

    Version of Record online : 25 MAR 2014, DOI: 10.1111/1756-2171.12040

  3. On the monopoly: Speculation, pharmaceutical markets, and intellectual property law in Nigeria

    American Ethnologist

    Volume 41, Issue 1, February 2014, Pages: 128–142, KRISTIN PETERSON

    Version of Record online : 16 FEB 2014, DOI: 10.1111/amet.12064

  4. Probabilistic Selling, Channel Structure, and Supplier Competition

    Decision Sciences

    Volume 44, Issue 2, April 2013, Pages: 267–296, Gangshu (George) Cai, Ying-Ju Chen, Chi-Cheng Wu and Lu Hsiao

    Version of Record online : 12 APR 2013, DOI: 10.1111/deci.12009

  5. Product Line Rivalry and Market Segmentation—with an Application to Automobile Optional Engine Pricing

    The Journal of Industrial Economics

    Volume 47, Issue 4, December 1999, Pages: 399–425, Frank Verboven

    Version of Record online : 27 MAR 2003, DOI: 10.1111/1467-6451.00106

  6. Generic Entry and the Pricing of Pharmaceuticals

    Journal of Economics & Management Strategy

    Volume 6, Issue 1, Spring 1997, Pages: 75–90, Richard G. Frank and David S. Salkever

    Version of Record online : 28 JAN 2004, DOI: 10.1111/j.1430-9134.1997.00075.x

  7. Recall and recognition of brand names: A comparison of word and nonword name types

    Psychology & Marketing

    Volume 19, Issue 7-8, July - August 2002, Pages: 621–639, Dawn Lerman and Ellen Garbarino

    Version of Record online : 31 MAY 2002, DOI: 10.1002/mar.10028

  8. A DYNAMIC OLIGOPOLY STRUCTURAL MODEL FOR THE PRESCRIPTION DRUG MARKET AFTER PATENT EXPIRATION

    International Economic Review

    Volume 51, Issue 4, November 2010, Pages: 1175–1207, Andrew T. Ching

    Version of Record online : 18 NOV 2010, DOI: 10.1111/j.1468-2354.2010.00615.x

  9. Patterns in spontaneous adverse event reporting among branded and generic antiepileptic drugs

    Clinical Pharmacology & Therapeutics

    Volume 97, Issue 5, May 2015, Pages: 508–517, J Bohn, C Kortepeter, M Muñoz, K Simms, S Montenegro and G Dal Pan

    Version of Record online : 3 APR 2015, DOI: 10.1002/cpt.81

  10. Generic substitution by hospital pharmacists in Thailand

    International Journal of Pharmacy Practice

    Volume 2, Issue 1, March 1993, Pages: 11–14, N. Charupatanapong and K. L. Rascati

    Version of Record online : 22 FEB 2011, DOI: 10.1111/j.2042-7174.1993.tb00711.x

  11. Pricing-to-Market and Market Structure

    Oxford Bulletin of Economics and Statistics

    Volume 70, Issue 2, April 2008, Pages: 155–180, Matteo Bugamelli and Roberto Tedeschi

    Version of Record online : 21 JAN 2008, DOI: 10.1111/j.1468-0084.2007.00493.x

  12. Monographs for Drug-Drug Interactions of Therapeutics Biologics

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Jocelyn Leu, Simone Kasek, Christine Li, Wararat Limothai, Dora Babu Madhura, Chetan Rathi, Sumit Rawal, Josiah Ryman, Margaret Thomson, Ashit Trivedi, Honghui Zhou and Bernd Meibohm

    Published Online : 19 JUN 2013, DOI: 10.1002/9780470571224.pse487

  13. Network competition with income effects

    The RAND Journal of Economics

    Volume 45, Issue 3, Fall 2014, Pages: 645–673, Thomas P. Tangerås

    Version of Record online : 25 JUL 2014, DOI: 10.1111/1756-2171.12066

  14. Does brand name imprinting in memory increase brand information retention?

    Psychology & Marketing

    Volume 20, Issue 12, December 2003, Pages: 1119–1135, William E. Baker

    Version of Record online : 20 NOV 2003, DOI: 10.1002/mar.10111

  15. Memory for advertising and information content: Comparing the printed page to the computer screen

    Psychology & Marketing

    Volume 22, Issue 8, August 2005, Pages: 623–648, Marilyn Y. Jones, Robin Pentecost and Gabrielle Requena

    Version of Record online : 20 JUN 2005, DOI: 10.1002/mar.20077

  16. Switch-backs associated with generic drugs approved using product-specific determinations of therapeutic equivalence

    Pharmacoepidemiology and Drug Safety

    Joshua J. Gagne, Jennifer M. Polinski, Wenlei Jiang, Sarah K. Dutcher, Jing Xie, Joyce Lii, Lisa A. Fulchino and Aaron S. Kesselheim

    Version of Record online : 22 APR 2016, DOI: 10.1002/pds.4009

  17. Testing hypotheses about fecundity, body size and maternal condition in fishes

    Fish and Fisheries

    Volume 5, Issue 2, June 2004, Pages: 120–130, Marten A. Koops, Jeffrey A. Hutchings and Tara M. McIntyre

    Version of Record online : 24 MAY 2004, DOI: 10.1111/j.1467-2979.2004.00149.x

  18. Disaggregate Wealth and Aggregate Consumption: an Investigation of Empirical Relationships for the G7

    Oxford Bulletin of Economics and Statistics

    Volume 65, Issue 2, May 2003, Pages: 197–220, Joseph P. Byrne and E. Philip Davis

    Version of Record online : 22 MAY 2003, DOI: 10.1111/1468-0084.00044

  19. Pharmaceutical Patents and Prices of Generics in Morocco and Neighboring Economies

    The Journal of World Intellectual Property

    Volume 15, Issue 2, March 2012, Pages: 103–132, Ahmed Driouchi and Nada Zouag

    Version of Record online : 13 MAR 2012, DOI: 10.1111/j.1747-1796.2012.00435.x

  20. Market power in aftermarkets

    Managerial and Decision Economics

    Volume 17, Issue 2, March 1996, Pages: 143–164, Benjamin Klein

    Version of Record online : 4 DEC 1998, DOI: 10.1002/(SICI)1099-1468(199603)17:2<143::AID-MDE759>3.0.CO;2-J